Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Neuraxpharm Aims For Sales Of €400m By Year End
The Projected Total Represents Organic Growth Of 10%
Oct 02 2019
•
By
Akriti Seth
Neuraxpharm’s presence in Europe has grown to nine countries • Source: Shutterstock
More from Earnings
More from Business